Literature DB >> 33655384

Regularity and Continuity of GP Contacts and Use of Statins Amongst People at Risk of Cardiovascular Events.

David Youens1,2, Jenny Doust3,4, Suzanne Robinson5, Rachael Moorin5,6.   

Abstract

BACKGROUND: Regularity and continuity of general practitioner (GP) contacts are associated with reduced hospitalisation. Opportunities for improved medication management are cited as a potential cause.
OBJECTIVE: Determine associations between continuity and regularity of primary care and statin use amongst individuals at risk of cardiovascular disease (CVD) outcomes.
DESIGN: Observational cohort study using self-report and administrative data from 267,153 participants of the Sax Institute's 45 and Up Study conducted in New South Wales, Australia. from 2006 to 2009. Medicare Benefits Schedule (MBS) and Pharmaceutical Benefits Scheme (PBS) data, from Services Australia, were linked to survey, hospital and death data by the NSW Centre for Health Record Linkage. PARTICIPANTS: The 45 and Up Study participants at risk of CVD outcomes based on self-report and administrative data, divided into existing users and potential users based on dispensing records through the exposure period. MAIN MEASURES: The Continuity of Care index (COC), measuring whether patients see the same GP, and an index assessing whether GP visits are on a regular basis, measured from July 2011 to June 2012. Amongst potential users, statin initiation from July 2012 to June 2013 was assessed using logistic regression; amongst existing users, adherence was assessed from July 2012 to June 2015 using Cox regression (non-adherence being 30 days without statins). KEY
RESULTS: Amongst 29,420 potential users, the most regular quintile had 1.22 times the odds of initiating statin (95%CI 1.11-1.34), while the high continuity group had an odds ratio of 1.12 (95%CI 1.02-1.24). Amongst 30,408 existing users, the most regular quintile had 0.82 the hazard of non-adherence (95%CI 0.78-0.87); the high continuity group had a hazard ratio of 0.89 (95%CI 0.84-0.94).
CONCLUSIONS: Regularity and continuity of care impact on medication management. It is possible that this mediates impacts on hospitalisation. Where there is a risk of unobserved confounding, potential causal pathways should be investigated.

Entities:  

Keywords:  adherence; continuity of care; general practice; statins

Mesh:

Substances:

Year:  2021        PMID: 33655384      PMCID: PMC8175539          DOI: 10.1007/s11606-021-06638-3

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   6.473


  48 in total

1.  Does continuity of care with a family physician reduce hospitalizations among older adults?

Authors:  Verena H Menec; Monica Sirski; Dhiwya Attawar; Alan Katz
Journal:  J Health Serv Res Policy       Date:  2006-10

2.  Higher Primary Care Physician Continuity is Associated With Lower Costs and Hospitalizations.

Authors:  Andrew Bazemore; Stephen Petterson; Lars E Peterson; Richard Bruno; Yoonkyung Chung; Robert L Phillips
Journal:  Ann Fam Med       Date:  2018-11       Impact factor: 5.166

3.  The crux of the matter: Did the ABC's Catalyst program change statin use in Australia?

Authors:  Andrea L Schaffer; Nicholas A Buckley; Timothy A Dobbins; Emily Banks; Sallie-Anne Pearson
Journal:  Med J Aust       Date:  2015-06-15       Impact factor: 7.738

4.  The effect of continuity of care on emergency department use.

Authors:  J M Gill; A G Mainous; M Nsereko
Journal:  Arch Fam Med       Date:  2000-04

5.  Copayments for general practice visits.

Authors:  Christopher B Del Mar
Journal:  Med J Aust       Date:  2014-04-21       Impact factor: 7.738

6.  Statin Adherence and Mortality in Patients Aged 80 Years and Older After Acute Myocardial Infarction.

Authors:  Derek Q Phan; Lewei Duan; Bryan Lam; Avetis Hekimian; David Wee; Ray Zadegan; Ming-Sum Lee
Journal:  J Am Geriatr Soc       Date:  2019-06-17       Impact factor: 5.562

7.  Is greater continuity of care associated with less emergency department utilization?

Authors:  D A Christakis; J A Wright; T D Koepsell; S Emerson; F A Connell
Journal:  Pediatrics       Date:  1999-04       Impact factor: 7.124

8.  Variables with time-varying effects and the Cox model: some statistical concepts illustrated with a prognostic factor study in breast cancer.

Authors:  Carine A Bellera; Gaëtan MacGrogan; Marc Debled; Christine Tunon de Lara; Véronique Brouste; Simone Mathoulin-Pélissier
Journal:  BMC Med Res Methodol       Date:  2010-03-16       Impact factor: 4.615

9.  Continuity of care, potentially inappropriate medication, and health care outcomes among the elderly: evidence from a longitudinal analysis in Taiwan.

Authors:  Hsuan-Yin Chu; Chi-Chen Chen; Shou-Hsia Cheng
Journal:  Med Care       Date:  2012-11       Impact factor: 2.983

10.  Measuring provider continuity in ambulatory care: an assessment of alternative approaches.

Authors:  D M Steinwachs
Journal:  Med Care       Date:  1979-06       Impact factor: 2.983

View more
  4 in total

1.  Measuring continuity of care in general practice: a comparison of two methods using routinely collected data.

Authors:  Sally A Hull; Crystal Williams; Peter Schofield; Kambiz Boomla; Mark Ashworth
Journal:  Br J Gen Pract       Date:  2022-06-28       Impact factor: 6.302

2.  Patient-reported continuity of care and the association with patient experience of cardiovascular prevention: an observational study in Germany.

Authors:  Christine Arnold; Patrick Hennrich; Michel Wensing
Journal:  BMC Prim Care       Date:  2022-07-18

3.  Associations between regular GP contact, diabetes monitoring and glucose control: an observational study using general practice data.

Authors:  David Youens; Suzanne Robinson; Jenny Doust; Mark N Harris; Rachael Moorin
Journal:  BMJ Open       Date:  2021-11-10       Impact factor: 3.006

4.  Association between continuity of primary care and both prescribing and adherence of common cardiovascular medications: a cohort study among patients in England.

Authors:  Peter Tammes; Rupert A Payne; Chris Salisbury
Journal:  BMJ Open       Date:  2022-09-13       Impact factor: 3.006

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.